Liposomes targeted via two different antibodies: Assay, B-cell binding and cytotoxicity
- 24 February 2005
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1711 (1) , 25-32
- https://doi.org/10.1016/j.bbamem.2005.02.007
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Improved Outcome When B-Cell Lymphoma Is Treated with Combinations of Immunoliposomal Anticancer Drugs Targeted to Both the CD19 and CD20 EpitopesClinical Cancer Research, 2004
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Ligand-targeted liposomal anticancer drugsProgress in Lipid Research, 2003
- Ligand-targeted therapeutics in anticancer therapyNature Reviews Cancer, 2002
- Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCSPublished by Elsevier ,2002
- A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancerBiochimica et Biophysica Acta (BBA) - Biomembranes, 2001
- In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approachBiochimica et Biophysica Acta (BBA) - Biomembranes, 2001
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000
- Immunoliposomes bearing polyethyleneglycol‐coupled Fab′ fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivoFEBS Letters, 1997
- Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivoBritish Journal of Cancer, 1996